Rep. Thomas H. Kean, Jr. Sells Stryker Corporation (NYSE:SYK) Shares

Representative Thomas H. Kean, Jr. (Republican-New Jersey) recently sold shares of Stryker Corporation (NYSE:SYK). In a filing disclosed on February 19th, the Representative disclosed that they had sold between $15,001 and $50,000 in Stryker stock on January 23rd. The trade occurred in the Representative’s “STATE STREET BANK & TRUST CO.” account.

Representative Thomas H. Kean, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 1/29/2026.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/23/2026.
• Sold $15,001 – $50,000 in shares of Johnson & Johnson (NYSE:JNJ) on 1/23/2026.
• Sold $15,001 – $50,000 in shares of Markel Group (NYSE:MKL) on 1/23/2026.
• Sold $1,001 – $15,000 in shares of General Motors (NYSE:GM) on 1/7/2026.
• Purchased $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 11/26/2025.

Stryker Stock Performance

Shares of Stryker stock traded down $2.45 on Tuesday, reaching $382.28. 732,296 shares of the stock were exchanged, compared to its average volume of 2,072,447. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $404.87. The business has a 50 day moving average price of $360.63 and a two-hundred day moving average price of $368.88. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $146.29 billion, a price-to-earnings ratio of 45.51, a PEG ratio of 2.22 and a beta of 0.87.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating the consensus estimate of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business had revenue of $7.17 billion during the quarter, compared to analysts’ expectations of $7.12 billion. During the same period in the previous year, the business posted $4.01 EPS. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. Analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be paid a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is presently 41.90%.

Hedge Funds Weigh In On Stryker

A number of hedge funds have recently made changes to their positions in the company. Brighton Jones LLC lifted its position in Stryker by 15.4% during the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares in the last quarter. WBH Advisory Inc. purchased a new position in shares of Stryker during the 2nd quarter worth $212,000. Schnieders Capital Management LLC. acquired a new position in shares of Stryker during the 2nd quarter valued at about $205,000. Pittenger & Anderson Inc. grew its holdings in shares of Stryker by 13.0% in the second quarter. Pittenger & Anderson Inc. now owns 3,050 shares of the medical technology company’s stock valued at $1,207,000 after purchasing an additional 350 shares during the period. Finally, Whittier Trust Co. increased its position in Stryker by 9.3% during the second quarter. Whittier Trust Co. now owns 4,466 shares of the medical technology company’s stock worth $1,767,000 after purchasing an additional 380 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insiders Place Their Bets

In related news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the transaction, the director directly owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 5.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on SYK shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Stryker in a research note on Monday, December 22nd. Robert W. Baird set a $437.00 price target on shares of Stryker in a research report on Friday, January 30th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $435.00 price objective on shares of Stryker in a research report on Friday, November 14th. The Goldman Sachs Group set a $399.00 target price on Stryker in a research report on Friday, January 9th. Finally, Sanford C. Bernstein upped their price target on Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a report on Friday, January 9th. Thirteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Stryker has a consensus rating of “Moderate Buy” and an average price target of $426.47.

About Representative Kean

Thomas Kean Jr. (Republican Party) is a member of the U.S. House, representing New Jersey’s 7th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Kean (Republican Party) is running for re-election to the U.S. House to represent New Jersey’s 7th Congressional District. He declared candidacy for the 2026 election.

Thomas Kean Jr. lives in Westfield, New Jersey. Kean earned a master’s degree from the Tufts University Fletcher School of Law and Diplomacy. His career experience includes working with the Environmental Protection Agency during the George H.W. Bush administration and as an advisor to former U.S. Representative Bob Franks, a firefighter, and an emergency medical technician. Kean has served as the vice president of a fire department.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.